Effectiveness of the Use of Three-Dose Intravitreal Ziv-Aflibercept in the Management of Diabetic Macular Edema in a Real-Life Setting.
Fernando Munayco-GuillénVazquez-Membrillo MiguelMarlon Rafael Garcia-RoaJhony Alberto De La Cruz-VargasHerney Andres García-PerdomoRafael Pichardo-RodríguezPublished in: Clinical ophthalmology (Auckland, N.Z.) (2023)
The use of three consecutive monthly doses of intravitreal Ziv-aflibercept in a real-life setting is effective and safe in the management of diabetic macular edema.